ArticleCell death discovery2026

VK-2019 enhances gemcitabine's antitumor activity in EBV-positive nasopharyngeal carcinoma by upregulating PRODH expression.

Chengxun Li et al.PubMed ↗Publisher ↗

No numbers read from the abstract.